Pharmaceuticals
Yuyu Pharma appoints Robert Wonsang Yu as incoming President and CEO
SEOUL, South Korea, April 5, 2020 /PRNewswire/ -- Yuyu Pharma (KRX: 000220), a
global pharmaceutical company based in Korea, is pleased to announce the
appointment of Mr.Robert Wonsang Yu as President and Chief Executive Officer
effectiveApril 6, 2020.
2020-04-06 08:00
1678
COVID-19 Antibody Test Released by Ortho Clinical Diagnostics
RARITAN, New Jersey, April 4, 2020 /PRNewswire/ -- Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 To...
2020-04-04 07:06
2761
Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China
GERMANTOWN, Maryland, April 3, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced the completion of its new cell manufacturing facility in Suzhou,China. The facilit...
2020-04-03 20:00
2367
CPhI & P-MEC China 2020 will join hands with P-Logi China 2020 and be held at Shanghai New International Expo Center in June
SHANGHAI, April 3, 2020 /PRNewswire/ -- To provide global vision and opportunities for the intelligent coordination between pharmaceutical enterprises and logistics service and equipment suppliers, P-Logi China 2020, organized by Informa Markets and CCCMHPIE and co-organized by Sinoexpo Informa ...
2020-04-03 17:02
2769
CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality
SUZHOU, China, April 3, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Mr. Ye Shi as the Head of Quality. He will be responsible for the overall management of the qual...
2020-04-03 09:12
4798
China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma
-- XEN® Becomes the First Medical Product Approved by Using Real World Evidence inChina -- DUBLIN, April 2, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN® Gel Stent on March 26, 202...
2020-04-02 19:30
7545
Covid-19 Related Delays in the Ongoing Phase IIb-study are Expected to be Managed With Existing Funding
STOCKHOLM, April 2, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, onApril 2 2020, that the company is now seeing signs of delays in the ongoing clinical phase IIb study with the drug candidate RV001 in prostate cancer, due to the Covid-19 pandemic. However, the company believes that ...
2020-04-02 17:17
1424
Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020
HANGZHOU and SHAOXING, China, April 1, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its partner Sagimet Biosciences (formerly 3-V Biosciences, Inc), will present clinical and preclinical data on non-alcoholic steatohepatitis (NASH) drug candidate TVB-2640 (Ascl...
2020-04-01 08:30
2902
Saxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity
BAGSVÆRD, Denmark, April 1, 2020 /PRNewswire/ -- Novo Nordisk today announced that theNew England Journal of Medicine published results of a phase 3 trial evaluating the investigational use of Saxenda® (liraglutide 3.0 mg) in adolescents (aged 12–<18) with obesity.1 The study was accepted for pr...
2020-04-01 00:00
1081
Yuyu Pharma introduces enhanced ERP system
SEOUL, South Korea, March 31, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert
Wonsang Yu, KRX 000220) introduced a new Enterprise Resource Planning (ERP)
system to identify real-time management conditions and enhance system
management for more efficient decision-making.
2020-03-31 21:00
1392
Yiling Pharmacy Lianhua Qingwen has been approved by the Ministry of Health of Thailand
SHIJIAZHUANG, China, March 31, 2020 /PRNewswire/ -- On March 31, Shijiazhuang Yiling Pharmaceutical Co., Ltd released a notice that they had received the approval of the modern herbal medicine registration issued by the ministry of health ofThailand. Lianhua Qingwen Capsule is recognized as in li...
2020-03-31 18:15
3044
Fosun Pharma Announces 2019 Annual Results
SHANGHAI, March 31, 2020 /PRNewswire/ -- On March 30 2020, Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK), a leading healthcare group in China, announced its annual results for the year 2019 ("the reporting period"). During the reporting period: ...
2020-03-31 17:51
11069
Yuyu Pharma introduces new advanced ERP management system
SEOUL, South Korea, March 31, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) introduced a new Enterprise Resource Planning (ERP) system to identify real-time management conditions and enhance system management for more efficient decision-making. The new ERP system took more...
2020-03-31 16:00
1339
3SBio Unveils 2019 Annual Results: Revenue Rises by 16.0%, Normalized Net Profit attributable to owners of the parent Jumps by19.4%, R&D Expenses Soar 45.2%
HONGKONG, March 31, 2020 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today released its 2019 annual results, showing that the Company maintained steady growth, with core products continuously leading the market and more products being included into drug reimbursemen...
2020-03-31 12:29
9445
Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group
SYDNEY, March 31, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Dr Gillies O'Bryan-Tear will be chairing Clarity's newly formed Global Clinical Development group. Dr O'Bryan-Tear joined the pha...
2020-03-31 12:10
1374
INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia
PLYMOUTH MEETING, Pennsylvania, March 30, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ: INO) today reported interim results from an open-label Phase 2 trial designed to evaluate the safety and efficacy of VGX-3100 in women with vulvar dysplasia, also known as high grade squamous int...
2020-03-30 21:00
2858
OssDsign Receives Regulatory Approval and Prepares for Launch in Japan
STOCKHOLM, March 30, 2020 /PRNewswire/ -- OssDsign AB (publ) today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of OssDsign Cranial PSI for the Japanese market. OssDsign plans to launch OssDsign Cranial PSI inJapan together with a national dis...
2020-03-30 20:42
1667
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest bySeptember 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capab...
2020-03-30 19:32
4554
Alphamab Oncology, Simcere and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China
SUZHOU, China, March 30, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966HK) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has established strategic partnership with Simcere and 3D Medicines (Beijing) Co....
2020-03-30 19:00
3378
CSPC Pharmaceutical Announces 2019 Annual Results
Profit Attributable To Shareholders Increased 20.6% to RMB3,714 Million Innovative Drug Business Continued to Deliver Strong Growth New Products Launched Helped to Sustain Growth HONG KONG, March 30, 2020 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the...
2020-03-30 12:34
3571
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5902
